Immunic
IMUX
52 hedge funds and large institutions have $146M invested in Immunic in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 4 reducing their positions, and 7 closing their positions.
525% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 4
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
18% more funds holding
Funds holding: 44 → 52 (+8)
16% more capital invested
Capital invested by funds: $125M → $146M (+$20.3M)
90% less call options, than puts
Call options by funds: $1.34M | Put options by funds: $13.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$20.3M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$13.8M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.13M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.64M |
| 2 |
SIM
Spark Investment Management
New York
|
-$1.47M |
| 3 |
DA
DSC Advisors
Chicago,
Illinois
|
-$1.12M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$750K |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$138K |
IMUX Hedge Fund Activity: Q2 2015 in Review
52 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2015, worth a combined $146M — up 16% from $125M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new IMUX positions and 7 closed out — a net gain of 8 holders — while 25 added to existing stakes and 4 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $20.3M. The largest seller was Fidelity Investments, cutting an estimated $6.64M.
- 52 institutional investors held Immunic (IMUX) as of Q2 2015, up from 44 in Q1 2015.
- Funds reported $146M of Immunic stock for Q2 2015, up 16% quarter-over-quarter.
- 15 funds opened new Immunic positions in Q2 2015 and 7 closed out, a net change of +8 holders.
- The largest Immunic buyer in Q2 2015 was T. Rowe Price Associates, an estimated $20.3M added.
- The largest Immunic seller in Q2 2015 was Fidelity Investments, an estimated $6.64M sold.
Based on aggregated 13F filings for Q2 2015.